ONCOLYTICS BIOTECH INC(ONCY)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ONCY Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for ONCOLYTICS BIOTECH INC (ONCY), a Healthcare sector company. ONCY is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), ONCOLYTICS BIOTECH INC reports net income of $-9.4M, free cash flow of $-8.1M. Top institutional holders of ONCY by reported 13-F value include MARSHALL WACE, LLP, XTX Topco Ltd, SEEDS INVESTOR, based on the most recent SEC filings. ONCY trades on the Nasdaq exchange and files with the SEC under CIK 1129928. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ONCY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ONCOLYTICS BIOTECH INC directly from SEC EDGAR.
Net Income
Q2 2026
$-9.4M
Free Cash Flow
Q2 2026
$-8.1M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-26.2% YoYOperating Income
-12.5% YoYEPS (Diluted)
+0.0% YoYTotal Assets
-43.5% YoYOp. Cash Flow
-1.2% YoYFree Cash Flow
-0.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-28.8M -26.2% | $-22.8M | — | — | — | — |
| Operating Income | $-28.7M -12.5% | $-25.5M | — | — | — | — |
| EPS (Diluted) | $-0.30 +0.0% | $-0.30 | — | — | — | — |
| Total Assets | $7.6M -43.5% | $13.4M -65.4% | $38.8M +4.0% | $37.3M -18.6% | $45.9M +33.6% | $34.3M |
| Operating Cash Flow | $-20.1M -1.2% | $-19.9M | — | — | — | — |
| Free Cash Flow | $-20.1M -0.3% | $-20.1M | — | — | — | — |
Get alerted when ONCY's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ONCOLYTICS BIOTECH INC including:
Top Institutional Holders of ONCY
MARSHALL WACE, LLP
$708.1K745,350 shXTX Topco Ltd
$247.8K260,903 shSEEDS INVESTOR LLC
$245.4K258,306 shINTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
$181.3K201,260 shConnective Capital Management, LLC
$176.4K185,712 shGOLDMAN SACHS GROUP INC
$161.4K169,898 shTOCQUEVILLE ASSET MANAGEMENT L.P.
$139.6K147,000 shEverhart Financial Group, Inc.
$133.8K140,899 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$127.4K134,129 shPFG Investments, LLC
$121.9K128,300 sh
| Fund | Value | Shares |
|---|---|---|
| MARSHALL WACE, LLP | $708.1K | 745,350 |
| XTX Topco Ltd | $247.8K | 260,903 |
| SEEDS INVESTOR LLC | $245.4K | 258,306 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $181.3K | 201,260 |
| Connective Capital Management, LLC | $176.4K | 185,712 |
| GOLDMAN SACHS GROUP INC | $161.4K | 169,898 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $139.6K | 147,000 |
| Everhart Financial Group, Inc. | $133.8K | 140,899 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $127.4K | 134,129 |
| PFG Investments, LLC | $121.9K | 128,300 |
More Healthcare Companies
View all Healthcare →Put ONCY on your watchlist
Track score changes the day ONCOLYTICS BIOTECH INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ONCY a good stock to buy?
13F Pro's AI-powered analysis of ONCOLYTICS BIOTECH INC (ONCY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ONCY are available on the ONCY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ONCY is classified as a small company.
Which hedge funds own ONCY?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ONCY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ONCOLYTICS BIOTECH INC's investment landscape.